Spotlight on Fluvoxamine in Anxiety Disorders in Children and Adolescents

ISSN： 1172-7047

Source： CNS Drugs, Vol.16, Iss.2, 2002-01, pp. : 139-144

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Fluvoxamine: A Review of its Therapeutic Potential in the Management of Anxiety Disorders in Children and Adolescents

By Cheer S.M. Figgitt D.P.

Pediatric Drugs, Vol. 3, Iss. 10, 2001-01 ,pp. : 763-781

Adis International

Access to resources Recommend Favorite

Treatment of Anxiety Disorders in Children and Adolescents

Child and Adolescent Psychopharmacology News, Vol. 19, Iss. 5, 2014-10 ,pp. : 1-7

Guilford Publications Inc

Access to resources Recommend Favorite

The pharmacological treatment of anxiety disorders in children and adolescents

By Hack Sabine Nash Lawrence T

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 5, 2002-05 ,pp. : 555-571

Informa Healthcare

Access to resources Recommend Favorite

A Risk-Benefit Assessment of Pharmacotherapy for Anxiety Disorders in Children and Adolescents

By Hawkridge S.M. Stein D.J.

Drug Safety, Vol. 19, Iss. 4, 1998-10 ,pp. : 283-297

Adis International

Access to resources Recommend Favorite

Anxiety and Social Relationships in Children and Adolescents

Child and Adolescent Psychopharmacology News, Vol. 7, Iss. 6, 2002-12 ,pp. : 10-12

Guilford Publications Inc

Access to resources Recommend Favorite